Clinical Trials Browser

Recruiting × Colorectal Neoplasms × penpulimab × Clear all

NCT05229003 2024-07-03

Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms